Jane Gross
Director/Board Member at ATYR PHARMA, INC.
Net worth: 9 570 $ as of 2024-04-29
Jane Gross active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATYR PHARMA, INC. | Director/Board Member | 2019-06-27 | - |
| Independent Dir/Board Member | 2019-06-27 | - | |
| BRIACELL THERAPEUTICS CORP. | Director/Board Member | 2021-10-31 | - |
| Independent Dir/Board Member | 2021-10-31 | - | |
| Washington Biotechnology & Biomedical Association | Director/Board Member | - | - |
BriaPro Therapeutics Corp.
 BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - |
Career history of Jane Gross
Former positions of Jane Gross
| Companies | Position | Start | End |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2016-08-31 | 2021-09-13 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 2011-06-30 | 2016-07-31 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 2009-01-31 | 2010-05-31 |
Training of Jane Gross
| University of California, Berkeley | Doctorate Degree |
Statistics
International
| United States | 7 |
| Canada | 2 |
| 2 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Private companies | 4 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Health Technology |
| BriaCell Therapeutics Corp. |
- Stock Market
- Insiders
- Jane Gross
- Experience
